FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2594180795> ?p ?o ?g. }

• W2594180795 abstract "Abstract [Background]Micafungin (MCFG) is a candin antifungal agent, and was marketed in Dec. 2002 in Japan and in Apr. 2005 in the United States. The Niigata Fungal Infection Study Group in Hematology (N-FISH) performed a multicenter prospective study to clarify the therapeutic effects of MCFG on deep fungal infections complicating hematological malignancies. [Methods]A total of 36 pts. who had been treated in centers belonging to N-FISH between Oct. 2003 and Apr. 2005 were included in this study. They consisted of 14 men and 22 women with a mean age of 53.5 years: 14 pts. with AML, 10 pts. with malignant lymphoma, 6 pts. with ALL, and 6 pts with other diseases. They had a proven fungal infection, or were suspected of having a fungal infection because of fever unresponsive to antimicrobial agents or from laboratory data. Three of them had a proven infection, and 33 were suspected of having a fungal infection. Three of these 33 pts. failed to respond to fluconazole. As a rule, MCFG was administered for more than 14 days until infectious symptoms improved or disappeared. When MCFG was judged ineffective because of the worsening of clinical symptoms despite the administration of MCFG, or when the administration of MCFG was judged difficult because of adverse effects, the drug was discontinued or replaced by other drugs. Two pts. orally received amphotericin B syrup singly. [Results]The mean dose of MCFG was 2.6 mg/kg (1.5–4.2 mg/kg), and the mean duration of administration was 15.9 days (5–85 days). Complete or partial response was achieved in 31 (86.1%) of the 36 pts., who showed improvements in infectious symptoms. In 4 pts, MCFG was discontinued because of insufficient effects. There were no breakthrough fungal infections within 7 days after the completion of MCFG therapy. Of the 36 pts., 31 (86.1%) and 24 (66.7%) survived 1 and 3 months after MCFG therapy, respectively. The cause of death was exacerbation of the primary disease, and not exacerbation or the onset of a fungal infection. Eight adverse events occurred in 7 pts.: hypoglycemia in 1, liver dysfunction in 3, eosinophilia in 1, kidney dysfunction in 2, and hypokalemia in 1. In 1 of the 3 pts. with liver dysfunction (grade 3), MCFG therapy was discontinued, with rapid improvement of the liver dysfunction. All other adverse events were mild, allowing continued MCFG therapy. [Conclusion]This multicenter study demonstrated the effectiveness and safety of MCFG therapy for deep fungal infections complicating hematological malignancies. The results suggest that MCFG should be promptly used for fever associated with a fungal infection complicating hematological malignancies." @default.
• W2594180795 created "2017-03-16" @default.
• W2594180795 creator A5016789715 @default.
• W2594180795 creator A5049683023 @default.
• W2594180795 creator A5055227838 @default.
• W2594180795 creator A5056443173 @default.
• W2594180795 creator A5057609314 @default.
• W2594180795 creator A5073606322 @default.
• W2594180795 creator A5080966484 @default.
• W2594180795 creator A5087588021 @default.
• W2594180795 creator A5089913354 @default.
• W2594180795 date "2005-11-16" @default.
• W2594180795 modified "2023-10-16" @default.
• W2594180795 title "Micafungin Is Extremely Effective Against Fungal Infections Complicating Hematological Malignancies: Report of a Multicenter Study by N-FISH (Niigata Fungal Infection Study Group in Hematology)." @default.
• W2594180795 doi "https://doi.org/10.1182/blood.v106.11.5350.5350" @default.
• W2594180795 hasPublicationYear "2005" @default.
• W2594180795 type Work @default.
• W2594180795 sameAs 2594180795 @default.
• W2594180795 citedByCount "0" @default.
• W2594180795 crossrefType "journal-article" @default.
• W2594180795 hasAuthorship W2594180795A5016789715 @default.
• W2594180795 hasAuthorship W2594180795A5049683023 @default.
• W2594180795 hasAuthorship W2594180795A5055227838 @default.
• W2594180795 hasAuthorship W2594180795A5056443173 @default.
• W2594180795 hasAuthorship W2594180795A5057609314 @default.
• W2594180795 hasAuthorship W2594180795A5073606322 @default.
• W2594180795 hasAuthorship W2594180795A5080966484 @default.
• W2594180795 hasAuthorship W2594180795A5087588021 @default.
• W2594180795 hasAuthorship W2594180795A5089913354 @default.
• W2594180795 hasConcept C126322002 @default.
• W2594180795 hasConcept C141071460 @default.
• W2594180795 hasConcept C16005928 @default.
• W2594180795 hasConcept C188816634 @default.
• W2594180795 hasConcept C194409129 @default.
• W2594180795 hasConcept C197934379 @default.
• W2594180795 hasConcept C2779020398 @default.
• W2594180795 hasConcept C2779548794 @default.
• W2594180795 hasConcept C2779629538 @default.
• W2594180795 hasConcept C2780651595 @default.
• W2594180795 hasConcept C71924100 @default.
• W2594180795 hasConcept C90924648 @default.
• W2594180795 hasConceptScore W2594180795C126322002 @default.
• W2594180795 hasConceptScore W2594180795C141071460 @default.
• W2594180795 hasConceptScore W2594180795C16005928 @default.
• W2594180795 hasConceptScore W2594180795C188816634 @default.
• W2594180795 hasConceptScore W2594180795C194409129 @default.
• W2594180795 hasConceptScore W2594180795C197934379 @default.
• W2594180795 hasConceptScore W2594180795C2779020398 @default.
• W2594180795 hasConceptScore W2594180795C2779548794 @default.
• W2594180795 hasConceptScore W2594180795C2779629538 @default.
• W2594180795 hasConceptScore W2594180795C2780651595 @default.
• W2594180795 hasConceptScore W2594180795C71924100 @default.
• W2594180795 hasConceptScore W2594180795C90924648 @default.
• W2594180795 hasLocation W25941807951 @default.
• W2594180795 hasOpenAccess W2594180795 @default.
• W2594180795 hasPrimaryLocation W25941807951 @default.
• W2594180795 hasRelatedWork W1979539699 @default.
• W2594180795 hasRelatedWork W1990164039 @default.
• W2594180795 hasRelatedWork W2099282982 @default.
• W2594180795 hasRelatedWork W2109923795 @default.
• W2594180795 hasRelatedWork W2151034395 @default.
• W2594180795 hasRelatedWork W2375550833 @default.
• W2594180795 hasRelatedWork W2392696719 @default.
• W2594180795 hasRelatedWork W2594180795 @default.
• W2594180795 hasRelatedWork W4243525728 @default.
• W2594180795 hasRelatedWork W4247382701 @default.
• W2594180795 isParatext "false" @default.
• W2594180795 isRetracted "false" @default.
• W2594180795 magId "2594180795" @default.
• W2594180795 workType "article" @default.